JM Herbert
Impact in
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
-
- Antiplatelet Therapy and Cardiovascular Diseases
- Atrial Fibrillation Management and Outcomes
Papers in
- Surgery 3
- Heparin-Induced Thrombocytopenia and Thrombosis 3
- Co-authors
- JP Maffrand (3 shared papers)Pierre Savi (2 shared papers)A. Bernat (2 shared papers)Jean Combalbert (1 shared paper)Yves Berger (1 shared paper)R. J. Paul (1 shared paper)Peter Carmeliet (1 shared paper)J.M. Lassalle (1 shared paper)
In The Last Decade
JM Herbert
11 papers receiving 376 citations
Peers
Comparison fields: 5 of 69
- Internal Medicine 86
- Cardiology and Cardiovascular Medicine 254
- Hematology 76
- Pharmacology 56
- Pharmacology 28
Countries citing papers authored by JM Herbert
This map shows the geographic impact of JM Herbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JM Herbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JM Herbert more than expected).
Fields of papers citing papers by JM Herbert
This network shows the impact of papers produced by JM Herbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JM Herbert. The network helps show where JM Herbert may publish in the future.
Co-authors
The 23 scholars most cited alongside JM Herbert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 226 | |
| 2 | 1992 | 89 | |
| 3 | Effect of heparin on the angiogenic potency of basic and acidic fibroblast growth factors in the rabbit cornea assay. | 1988 | 19 |
| 4 | Effect of SR 27417 on the binding of [3H]PAF to rabbit and human platelets and human polymorphonuclear leukocytes. | 1993 | 16 |
| 5 | In vitro and ex vivo regulation of vascular smooth muscle cell growth and phenotypic modulation by sulphated polysaccharides. | 1988 | 13 |
| 6 | Comparison of a low-molecular-weight heparin (nadroparin calcium) and unfractionated heparin as adjunct to coronary thrombolysis with alteplase and aspirin in dogs. | 1995 | 11 |
| 7 | Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist. | 1993 | 11 |
| 8 | Ex vivo effects of SR 27417, a novel PAF antagonist, on rabbit platelet aggregation and [3H]-PAF binding. | 1992 | 8 |
| 9 | 1992 | 7 | |
| 10 | Life-threatening thrombosis in mice with targeted Arg47 to cys mutation of the heparin binding domain of antithrombin | 2001 | 4 |
| 11 | 1988 | 2 |
About JM Herbert
JM Herbert is a scholar working on Surgery, Molecular Biology, Pharmacology, Hematology and Organic Chemistry, having authored 11 papers that have together received 406 indexed citations. Recurring topics across this work include Heparin-Induced Thrombocytopenia and Thrombosis (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Pharmacological Effects of Natural Compounds (2 papers), Proteoglycans and glycosaminoglycans research (2 papers), Traditional Chinese Medicine Analysis (2 papers), Pharmacogenetics and Drug Metabolism (1 paper) and Coordination Chemistry and Organometallics (1 paper). The work is most often cited by research in Internal Medicine (86 citations), Cardiology and Cardiovascular Medicine (254 citations), Hematology (76 citations), Pharmacology (56 citations) and Pharmacology (28 citations). JM Herbert has collaborated with scholars based in France and Belgium. Frequent co-authors include JP Maffrand, Pierre Savi, A. Bernat, Jean Combalbert, Yves Berger, R. J. Paul, Peter Carmeliet, J.M. Lassalle, Jef Arnout and Désiré Collen. Their work appears in journals such as Blood, Thrombosis and Haemostasis, Circulation, Australian Journal of Chemistry and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.